NIH Change to annual progress reports received on/after 10/1/14
National Institutes of Health (NIH) annual progress reports received on or after October 1, 2014 must include a section to describe how individual development plans (IDPs) are used to identify and promote the career goals of graduate students and postdoctoral researchers associated with the award.
See more at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-113.html.
Ohio Third Frontier (OTF), Ohio Development Services Agency
The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:
Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.
Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.
The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.
Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or firstname.lastname@example.org.
For more information on the TVSF visit the Ohio Third Frontier website.
NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)
The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)
Announces the Request for Applications (RFA) for the third funding cycle.
Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. NCAI-CC is seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders). Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.
Eligibility: Investigators from the Cleveland Clinic, Case Western Reserve University, The Ohio State University,Cincinnati Children’s Hospital, and University of Cincinnati
Letter of Intent Deadline: February 10, 2015
For more information visit the NCAI-CC website.
Research ShowCASE and Spring Intersections: Discovery, Collaboration & Community
Friday, April 17, 2015
9:00 am – 3:00 pm
Veale Convocation Center
Case Western Reserve University
The CWRU Office of Research and Technology Management and SOURCE (Support of Undergraduate Research and Creative Endeavors) are pleased to announce the opening of the Call for Presentations for Research ShowCASE 2015.
We invite you to participate with other CWRU faculty, staff and students by presenting your work at Research ShowCASE 2015. The event will provide an opportunity for you to display your research in a traditional scientific poster or other creative means. We encourage University Hospitals, Cleveland Clinic, MetroHealth Medical Center and the Louis Stokes Cleveland VA Medical Center researchers to participate.
In addition to the opportunity to display and share your work, undergraduate and graduate students, professional students and postdoctoral scholars are encouraged to participate in the research competition, which will include having your presentation evaluated and feedback provided. Prizes will be awarded to winning entries.
In order to display your work at Research ShowCASE, you will need to submit an online abstract describing your research. If you are a student or post-doc, your faculty advisor will need to approve your submission.
New this year:
Abstract Submission Deadline: February 15, 2015 (for graduate students, post-docs, professional students, faculty and staff)
- You will need to provide a brief description of your research in non-scientific terms
- You will be given the opportunity to provide a video abstract of your work in addition to the written abstract
- If you provide a 140-character title or description of your entry, we will tweet about your work
Undergraduate submissions will be accepted between February 16, 2015 and March 20, 2015.
Find out more and submit your abstract at: showCASE.case.edu.
amfAR, The Foundation for AIDS Research
amfAR, The Foundation for AIDS Research, has announced the availability of funding to support research relevant to exploring HIV persistence and the potential for HIV eradication. amfAR has established a new funding mechanism known as Impact Grants to support the in-depth development of concepts where preliminary data have indicated genuine promise in curing HIV. Impact Grants are conducted over a four-year funding period with up to $2,000,000 in total funding (including up to 20% indirect costs) and should include basic, animal and clinical (in vivo or ex vivo) research. Impact Grants aim to directly inform clinical efforts to safely eliminate or control latent/persistent HIV reservoirs. Priority will be given to projects with a clear pathway to development of an implementable intervention in humans.
Total Cost Maximum: $2,000,000
Performance Period: 4 years (July 1, 2015 – June 30, 2019)
Portal Request Form Deadline: Friday, February 27, 2015, 3:00 PM ET
Letter of Intent Submission Deadline: Tuesday, March 3, 2015, 3:00 PM ET
Hardcopy of Signed Face Page By Mail: Tuesday, March 24, 2015
For more information and to review the complete RFP visit the amfAR website.
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
email@example.com no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be